Urinalysis is a test of urine that is done to manage and detect a wide range of disorder such as diabetes, urinary tract infections, kidney disease, and others. Urinalysis validated urine content, concertation, and appurtenance and if the result is abnormal then the person is suffering from some disease or illness. The main applications of urinalysis are monitor overall health, diagnose a medical condition and monitor a medical condition. Increasing kidney diseases and urinary tract infections are the main key driver for the market. Additionally, Increasing Patients suffering from chronic diseases due to change in environment and lifestyle, demand for fast testing and shift towards automation in sediment analysis have been supplementing the overall growth of the market. However, rising health awareness across the globe and high cost of the automated analyzer are reasons that are limiting the growth of the market. Moreover, the emergence of integrated systems for a urinalysis and increasing demand from developing economies may act as a driver in coming years.According to AMA, the market for Urinalysis is expected to register a CAGR of 8.1% during the forecast period to 2024. This growth is primarily driven by Increasing Patients That Are Suffering From Kidney Diseases and Urinary Tract Infections, Demand for Fast Testing and Shift towards Automation in Sediment Analysis and Increasing Patients Suffering from chronic diseases due to change in environment and lifestyle.
Globally, a noticeable market trend is evident Rising Trend of Point-Of-Care Urinalysis Leads to High Adoption of it. Major Players, such as Cardinal Health, Inc. (United States), Alere, Inc. (United States), Siemens Healthineers (Germany), Roche Holding AG (Switzerland), Beckman Coulter Inc. (United States), Sysmex Corporation (Japan), Quidel Corporation (United States), Bio-Rad Laboratories, Inc. (United States), ARKRAY Healthcare Pvt. Ltd. (India) and Acon Laboratories, Inc. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
On September 2018, TestCard (the United States Based Company) has raised (USD 1.7 Million) in funding from small Bulgarian investment firm and Neo Ventures as the company has designed digitally-enabled home urine test. The new product can create a big opportunity for the company.
- Increasing Patients That Are Suffering From Kidney Diseases and Urinary Tract Infections
- Demand for Fast Testing and Shift towards Automation in Sediment Analysis
- Increasing Patients Suffering from chronic diseases due to change in environment and lifestyle
- Rising Trend of Point-Of-Care Urinalysis Leads to High Adoption of it
- Rising Health Awareness across Globe
High Demand from Emerging Economies and The Emergence of Integrated Systems for Urinalysis
High Cost of Automated Analyzer
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase